ArticleLeukemia2018

Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition?

Charlotte Pawlyn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.